Industry Asks CMS To Allow More Medtech Input, Longer-Term Metrics In Bundled Pay Models
Executive Summary
Industry groups told the US Medicare agency it should seek the input of a broader array of stakeholders – including medtech companies – in developing future episode-of-care pay models. They also argued that participation in the programs should be voluntary, and that the pay models should account for patient outcomes longer than 90 days following initial care. The responses came in comments to CMS following its proposal to scale back its joint replacement bundled payments program and eliminate a cardiac-care version.
You may also be interested in...
Trump Administration, Industry Want Stark Law Changes To Accommodate ACO Formation
The US administration and the medical device industry are pushing Congress to create exceptions and waivers to Stark law requirements that prohibit physician self-referrals to radiological clinics or other medical facilities in which they have a financial interest. They say the law inhibits formation of accountable care organizations fostered by the Centers for Medicare and Medicaid Services, and hinders value-based health care.
US House Panelists Fault CMS For Cutbacks To Joint Replacement Bundled-Pay Program
The US Centers for Medicare and Medicaid Services' decision last fall to limit a joint replacement bundled program met with considerable pushback from lawmakers this week.
Could CMS Changes To Bundled Pay Models Stifle Medtechs' Value-Based Pay Plans?
The US Center for Medicare and Medicaid Services proposed downsizing its CJR joint replacement value-based payment model and outright canceling its cardiac procedure bundled payment model. Will the move discourage companies like Zimmer Biomet, Johnson & Johnson, and Medtronic, which have already invested in programs based on the value-based models?